Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 3/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CHRNB3 | Q05901 | 1/20 | 0.32 |
| ▸ | CHRNA6 | Q15825 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ACE | P12821 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL890380 | 0.93 | CHRNB2 (0.36) | CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7 | |
| SCHEMBL4279 | 0.93 | — | — | |
| SCHEMBL1506461 | 0.93 | CHRNB2 (0.36) | CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7 | |
| SCHEMBL1060400 | 0.93 | CHRNB2 (0.36) | CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7 | |
| Hydrochloric Acid SCHEMBL1880027 | 0.90 | — | — | |
| SCHEMBL11819878 | 0.88 | — | — | |
| Bicarbonate SCHEMBL27911841 | 0.87 | LMNA (0.35) | CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7 | |
| SCHEMBL13044828 | 0.84 | CHRNB2 (0.37) | CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7 | |
| SCHEMBL21391917 | 0.84 | CES2 (0.43) | CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7 | |
| SCHEMBL2153805 | 0.84 | CHRNB2 (0.37) | CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3279181-B1 | METHOD FOR PRODUCING A MIXTURE OF A POLYMERIZABLE COMPOUND | ZEON CORP (JP) | 2021-08-04 | — | — | EP | disclosed |
| US-10934246-B2 | Mixture of polymerizable compound and method of producing the same | ZEON CORPORATION (JP) | 2021-03-02 | — | — | US | disclosed |
| US-20200148622-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD OF PRODUCING THE SAME | ZEON CORPORATION (JP) | 2020-05-14 | — | — | US | disclosed |
| US-10577306-B2 | Mixture of polymerizable compound and method of producing the same | ZEON CORPORATION (JP) | 2020-03-03 | — | — | US | disclosed |
| US-20180099921-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD OF PRODUCING THE SAME | ZEON CORPORATION (JP) | 2018-04-12 | — | — | US | disclosed |
| EP-3279181-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD FOR PRODUCING SAME | Zeon Corporation (JP) | 2018-02-07 | — | — | EP | disclosed |
| US-20160053116-A1 | POLYMER SOLUTION, POLYMER FILM, STACKED COMPOSITE, DISPLAY ELEMENT, OPTICAL ELEMENT, ILLUMINATION ELEMENT, AND PRODUCTION METHOD THEREFOR | SUMITOMO BAKELITE CO., LTD. (JP) | 2016-02-25 | — | — | US | disclosed |
| EP-1564237-B1 | ALICYCLIC OR AROMATIC POLYAMIDES, POLYAMIDE FILMS, OPTICAL MEMBERS MADE BY USING THE SAME, AND POLYAMIDE COPOLYMERS | TORAY INDUSTRIES (JP) | 2013-12-25 | — | — | EP | disclosed |
| US-8153753-B2 | Alicyclic or aromatic polyamides, polyamide films, optical members made by using the same, and polyamide copolymers | TORAY INDUSTRIES, INC. (JP) | 2012-04-10 | — | — | US | disclosed |
| US-20060106193-A1 | Alicyclic or aromatic polyamides, polyamide films, optical members made by using the same, and polyamide copolymers | TORAY INDUSTRIES,. (JP) | 2006-05-18 | — | — | US | disclosed |
| WO-1992020227-A1 | SUBSTITUTED ORALLY EFFECTIVE ION CHELATORS RELATED TO DEFEROXAMINE | ORAL-D (US) | 1992-11-26 | — | — | WO | disclosed |
| US-5047421-A | Treating trivalent metal overload conditions in humans | ORAL-D (US) | 1991-09-10 | — | — | US | disclosed |
| US-5015664-A | Orally effective ion chelators related to deferoxamine | ORAL D (US) | 1991-05-14 | — | — | US | disclosed |
| US-4684482-A | DEFEROXAMINE DERIVATIVES | ORAL-D (L.P.) (US) | 1987-08-04 | — | — | US | disclosed |
| US-4671901-A | DIFEROXAMINE DERIVATIVES FOR REDUCTION OF METAL ION TUSSUE OV ERLOAD | ORAL-D (US) | 1987-06-09 | — | — | US | disclosed |
| EP-0171414-A1 | ORALLY EFFECTIVE ION CHELATORS RELATED TO DEFEROXAMINE. | ORAL D (US) | 1986-02-19 | — | — | EP | disclosed |
| WO-1985003290-A1 | ORALLY EFFECTIVE ION CHELATORS RELATED TO DEFEROXAMINE | ORAL-D (US) | 1985-08-01 | — | — | WO | disclosed |
| US-4014922-A | CYCLOPROPYL SUBSTITUTED ESTERS; MITICIDES | ZOECON CORPORATION (US) | 1977-03-29 | — | — | US | disclosed |
| US-3954730-A | ANTIBIOTICS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-04 | — | — | US | disclosed |
| US-3948961-A | CYCLOPROPYL ALKYL CARBOXYLATES, MITICIDE, INSECTICIDE | ZOECON CORPORATION (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10934246-B2 | Mixture of polymerizable compound and method of producing the same | DDT, CA4, DNMT3B | CHRNB2 2215/4885CHRNA3 2456/4885CHRNA4 1372/4885 |
| US-20180099921-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD OF PRODUCING THE SAME | DDT, CA4, DNMT3B | CHRNB2 2215/4885CHRNA3 2456/4885CHRNA4 1372/4885 |
| US-20200148622-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD OF PRODUCING THE SAME | DDT, CA4, DNMT3B | CHRNB2 2215/4885CHRNA3 2456/4885CHRNA4 1372/4885 |
| US-10577306-B2 | Mixture of polymerizable compound and method of producing the same | DDT, CA4, DNMT3B | CHRNB2 2215/4885CHRNA3 2456/4885CHRNA4 1372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.